Literature DB >> 24091817

Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits.

Fatma Berri1, Vuong Ba Lê, Martine Jandrot-Perrus, Bruno Lina, Béatrice Riteau.   

Abstract

Influenza viruses cause acute respiratory infections, which are highly contagious and occur as seasonal epidemic and sporadic pandemic outbreaks. Innate immune response is activated shortly after infection with influenza A viruses (IAV), affording effective protection of the host. However, this response should be tightly regulated, as insufficient inflammation may result in virus escape from immunosurveillance. In contrast, excessive inflammation may result in bystander lung tissue damage, loss of respiratory capacity, and deterioration of the clinical outcome of IAV infections. In this review, we give a comprehensive overview of the innate immune response to IAV infection and summarize the most important findings on how the host can inappropriately respond to influenza.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24091817     DOI: 10.1007/s00018-013-1479-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  124 in total

1.  Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon.

Authors:  X Wang; M Li; H Zheng; T Muster; P Palese; A A Beg; A García-Sastre
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  RIG-I detects viral genomic RNA during negative-strand RNA virus infection.

Authors:  Jan Rehwinkel; Choon Ping Tan; Delphine Goubau; Oliver Schulz; Andreas Pichlmair; Katja Bier; Nicole Robb; Frank Vreede; Wendy Barclay; Ervin Fodor; Caetano Reis e Sousa
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

3.  The multibasic cleavage site of the hemagglutinin of highly pathogenic A/Vietnam/1203/2004 (H5N1) avian influenza virus acts as a virulence factor in a host-specific manner in mammals.

Authors:  Amorsolo L Suguitan; Yumiko Matsuoka; Yuk-Fai Lau; Celia P Santos; Leatrice Vogel; Lily I Cheng; Marlene Orandle; Kanta Subbarao
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

Review 4.  The immunotolerance role of HLA-G.

Authors:  N Rouas-Freiss; I Khalil-Daher; B Riteau; C Menier; P Paul; J Dausset; E D Carosella
Journal:  Semin Cancer Biol       Date:  1999-02       Impact factor: 15.707

5.  Plasma soluble human leukocyte antigen-G expression is a potential clinical biomarker in patients with hepatitis B virus infection.

Authors:  Wei-Wu Shi; Aifen Lin; Dan-Ping Xu; Wei-Guang Bao; Jian-Gang Zhang; Shi-Yong Chen; Jun Li; Wei-Hua Yan
Journal:  Hum Immunol       Date:  2011-07-01       Impact factor: 2.850

6.  Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation.

Authors:  Clemens Feistritzer; Matthias Riewald
Journal:  Blood       Date:  2004-12-30       Impact factor: 22.113

Review 7.  Fibrin and fibrinolysis in infection and host defense.

Authors:  J L Degen; T H Bugge; J D Goguen
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

8.  Inflammasome recognition of influenza virus is essential for adaptive immune responses.

Authors:  Takeshi Ichinohe; Heung Kyu Lee; Yasunori Ogura; Richard Flavell; Akiko Iwasaki
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

9.  Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis.

Authors:  Fatma Berri; Guus F Rimmelzwaan; Michel Hanss; Emmanuel Albina; Marie-Laure Foucault-Grunenwald; Vuong B Lê; Stella E Vogelzang-van Trierum; Patrica Gil; Eric Camerer; Dominique Martinez; Bruno Lina; Roger Lijnen; Peter Carmeliet; Béatrice Riteau
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

10.  Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury.

Authors:  Yumiko Imai; Keiji Kuba; G Greg Neely; Rubina Yaghubian-Malhami; Thomas Perkmann; Geert van Loo; Maria Ermolaeva; Ruud Veldhuizen; Y H Connie Leung; Hongliang Wang; Haolin Liu; Yang Sun; Manolis Pasparakis; Manfred Kopf; Christin Mech; Sina Bavari; J S Malik Peiris; Arthur S Slutsky; Shizuo Akira; Malin Hultqvist; Rikard Holmdahl; John Nicholls; Chengyu Jiang; Christoph J Binder; Josef M Penninger
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

View more
  19 in total

Review 1.  Multiple roles of the coagulation protease cascade during virus infection.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

Review 2.  The inflammatory response triggered by Influenza virus: a two edged sword.

Authors:  Luciana P Tavares; Mauro M Teixeira; Cristiana C Garcia
Journal:  Inflamm Res       Date:  2016-10-15       Impact factor: 4.575

Review 3.  Dietary selenium in adjuvant therapy of viral and bacterial infections.

Authors:  Holger Steinbrenner; Saleh Al-Quraishy; Mohamed A Dkhil; Frank Wunderlich; Helmut Sies
Journal:  Adv Nutr       Date:  2015-01-15       Impact factor: 8.701

4.  Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice.

Authors:  Angel S Galabov; Milka Mileva; Lora Simeonova; Galina Gegova
Journal:  Antivir Chem Chemother       Date:  2016-06-24

5.  Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication.

Authors:  Fatma Berri; Ghina Haffar; Vuong Ba Lê; Anne Sadewasser; Katharina Paki; Bruno Lina; Thorsten Wolff; Béatrice Riteau
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

6.  Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections.

Authors:  Vuong Ba Lê; Béatrice Riteau; Marie-Christine Alessi; Christian Couture; Martine Jandrot-Perrus; Chantal Rhéaume; Marie-Ève Hamelin; Guy Boivin
Journal:  Br J Pharmacol       Date:  2017-12-10       Impact factor: 8.739

Review 7.  FPR2: A Novel Promising Target for the Treatment of Influenza.

Authors:  Marie-Christine Alessi; Nicolas Cenac; Mustapha Si-Tahar; Béatrice Riteau
Journal:  Front Microbiol       Date:  2017-09-05       Impact factor: 5.640

Review 8.  Host Immunological Factors Enhancing Mortality of Young Adults during the 1918 Influenza Pandemic.

Authors:  Julie L McAuley; Katherine Kedzierska; Lorena E Brown; G Dennis Shanks
Journal:  Front Immunol       Date:  2015-08-19       Impact factor: 7.561

9.  Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets.

Authors:  Marco Goeijenbier; Eric C M van Gorp; Judith M A Van den Brand; Koert Stittelaar; Kamran Bakhtiari; Joris J T H Roelofs; Geert van Amerongen; Thijs Kuiken; Byron E E Martina; Joost C M Meijers; Albert D M E Osterhaus
Journal:  BMC Microbiol       Date:  2014-05-30       Impact factor: 3.605

10.  Involvement of the different lung compartments in the pathogenesis of pH1N1 influenza virus infection in ferrets.

Authors:  Beatriz Vidaña; Jorge Martínez; Jaime Martorell; María Montoya; Lorena Córdoba; Mónica Pérez; Natàlia Majó
Journal:  Vet Res       Date:  2016-11-08       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.